ATE449084T1 - Derivate von heterocyclen und arzneistoffe - Google Patents
Derivate von heterocyclen und arzneistoffeInfo
- Publication number
- ATE449084T1 ATE449084T1 AT01917752T AT01917752T ATE449084T1 AT E449084 T1 ATE449084 T1 AT E449084T1 AT 01917752 T AT01917752 T AT 01917752T AT 01917752 T AT01917752 T AT 01917752T AT E449084 T1 ATE449084 T1 AT E449084T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- different
- same
- group
- hydrogen atom
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 208000002193 Pain Diseases 0.000 abstract 2
- 230000000202 analgesic effect Effects 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 208000007514 Herpes zoster Diseases 0.000 abstract 1
- 208000004454 Hyperalgesia Diseases 0.000 abstract 1
- 102100028646 Nociceptin receptor Human genes 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 206010053552 allodynia Diseases 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002993 cycloalkylene group Chemical group 0.000 abstract 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- -1 nitro, hydroxy Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 108010020615 nociceptin receptor Proteins 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000098874 | 2000-03-31 | ||
| JP2000336464 | 2000-11-02 | ||
| PCT/JP2001/002822 WO2001072710A1 (en) | 2000-03-31 | 2001-03-30 | Heterocycle derivatives and drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE449084T1 true ATE449084T1 (de) | 2009-12-15 |
Family
ID=26589216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01917752T ATE449084T1 (de) | 2000-03-31 | 2001-03-30 | Derivate von heterocyclen und arzneistoffe |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6794389B2 (enExample) |
| EP (1) | EP1306372B1 (enExample) |
| KR (1) | KR20020083533A (enExample) |
| CN (1) | CN1242993C (enExample) |
| AT (1) | ATE449084T1 (enExample) |
| AU (1) | AU2001244688A1 (enExample) |
| CA (1) | CA2403605A1 (enExample) |
| DE (1) | DE60140545D1 (enExample) |
| RU (1) | RU2268260C2 (enExample) |
| WO (1) | WO2001072710A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL359918A1 (en) * | 2000-09-20 | 2004-09-06 | Merck Patent Gmbh | 4-amino-quinazolines |
| DE60132484T2 (de) | 2000-11-02 | 2009-01-15 | Nippon Shinyaku Co., Ltd. | Chinazolinderivate und -arzneimittel |
| CN1509184A (zh) * | 2001-03-19 | 2004-06-30 | �ձ���ҩ��ʽ���� | 止痒剂 |
| US6907295B2 (en) * | 2001-08-31 | 2005-06-14 | Biocontrol Medical Ltd. | Electrode assembly for nerve control |
| US7829566B2 (en) * | 2001-09-17 | 2010-11-09 | Werner Mederski | 4-amino-quinazolines |
| KR20040106391A (ko) * | 2002-04-26 | 2004-12-17 | 니뽄 신야쿠 가부시키가이샤 | 퀴나졸린 유도체 및 의약 |
| JP4805234B2 (ja) * | 2002-12-16 | 2011-11-02 | キッセイ薬品工業株式会社 | 経口固形医薬 |
| AU2004253967B2 (en) | 2003-07-03 | 2010-02-18 | Cytovia, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| JP2007524673A (ja) * | 2004-01-23 | 2007-08-30 | アムジエン・インコーポレーテツド | バニロイド受容体リガンドと治療におけるその使用 |
| EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | COMPOUNDS AND ITS THERAPEUTIC USE |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| EP1944298B1 (en) * | 2005-10-03 | 2013-01-09 | Nippon Shinyaku Co., Ltd. | Quinazoline derivative and pharmaceutical |
| RU2314295C2 (ru) * | 2006-03-01 | 2008-01-10 | Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Южный Федеральный Университет" | 2-гетарилзамещенные 1,3-трополона, способ их получения (варианты) и фармацевтическая композиция антимикробного действия |
| CA2685888A1 (en) * | 2007-05-09 | 2008-11-20 | Pfizer Inc. | Substituted heterocyclic derivatives and their pharmaceutical use and compositions |
| EP2017294A1 (de) | 2007-07-16 | 2009-01-21 | Sika Technology AG | Hitzehärtender Schaum |
| KR101714799B1 (ko) | 2008-12-30 | 2017-03-09 | 아르퀼 인코포레이티드 | 치환된 5,6-디히드로-6-페닐벤조［ｆ］이소퀴놀린-2-아민 화합물 |
| WO2012027495A1 (en) | 2010-08-27 | 2012-03-01 | University Of The Pacific | Piperazinylpyrimidine analogues as protein kinase inhibitors |
| JP5868168B2 (ja) | 2011-12-28 | 2016-02-24 | 富士フイルム株式会社 | 新規なニコチンアミド誘導体またはその塩 |
| WO2024258849A2 (en) * | 2023-06-13 | 2024-12-19 | The Trustees Of Indiana University | Small molecule antiviral drug treatment for human papillomavirus infections |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3753981A (en) * | 1970-07-15 | 1973-08-21 | Squibb & Sons Inc | 4-amino-2-styrylquinazoline compounds |
| PT100905A (pt) | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| JP2657760B2 (ja) | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | ４−アミノキナゾリン誘導体およびそれを含有する医薬品 |
| WO1997020821A1 (en) * | 1995-12-01 | 1997-06-12 | Novartis Ag | Heteroaryl derivatives |
| WO1998017267A1 (en) | 1996-10-23 | 1998-04-30 | Zymogenetics, Inc. | Compositions and methods for treating bone deficit conditions |
| CA2226058C (en) | 1997-01-30 | 2008-01-29 | F. Hoffmann-La Roche Ag | 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| AR012634A1 (es) | 1997-05-02 | 2000-11-08 | Sugen Inc | Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion |
| EP0990653B1 (en) | 1997-05-30 | 2004-09-15 | Banyu Pharmaceutical Co., Ltd. | 2-oxoimidazole derivatives |
| WO1999009986A1 (en) * | 1997-08-22 | 1999-03-04 | Kyowa Hakko Kogyo Co., Ltd. | 4-aminoquinazoline derivatives |
| NZ507760A (en) | 1998-03-26 | 2002-10-25 | Japan Tobacco Inc | Amide derivatives and nociceptin antagonists |
| CN1509184A (zh) * | 2001-03-19 | 2004-06-30 | �ձ���ҩ��ʽ���� | 止痒剂 |
-
2001
- 2001-03-30 US US10/239,750 patent/US6794389B2/en not_active Expired - Fee Related
- 2001-03-30 AU AU2001244688A patent/AU2001244688A1/en not_active Abandoned
- 2001-03-30 RU RU2002129100/04A patent/RU2268260C2/ru not_active IP Right Cessation
- 2001-03-30 EP EP01917752A patent/EP1306372B1/en not_active Expired - Lifetime
- 2001-03-30 CA CA002403605A patent/CA2403605A1/en not_active Abandoned
- 2001-03-30 DE DE60140545T patent/DE60140545D1/de not_active Expired - Lifetime
- 2001-03-30 AT AT01917752T patent/ATE449084T1/de not_active IP Right Cessation
- 2001-03-30 WO PCT/JP2001/002822 patent/WO2001072710A1/ja not_active Ceased
- 2001-03-30 CN CNB018075347A patent/CN1242993C/zh not_active Expired - Fee Related
- 2001-03-30 KR KR1020027012917A patent/KR20020083533A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| RU2002129100A (ru) | 2004-02-27 |
| KR20020083533A (ko) | 2002-11-02 |
| CA2403605A1 (en) | 2002-09-18 |
| DE60140545D1 (enExample) | 2009-12-31 |
| WO2001072710A1 (en) | 2001-10-04 |
| EP1306372B1 (en) | 2009-11-18 |
| RU2268260C2 (ru) | 2006-01-20 |
| EP1306372A4 (en) | 2004-03-17 |
| CN1242993C (zh) | 2006-02-22 |
| AU2001244688A1 (en) | 2001-10-08 |
| CN1422255A (zh) | 2003-06-04 |
| US20030119855A1 (en) | 2003-06-26 |
| US6794389B2 (en) | 2004-09-21 |
| EP1306372A1 (en) | 2003-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE449084T1 (de) | Derivate von heterocyclen und arzneistoffe | |
| DK1357111T3 (da) | 2-pyridonderivater med affinitet for cannabinoid type 2-receptor | |
| ATE208776T1 (de) | Pyrazolo(1,5-a) pyrimidin-derivate | |
| ATE80617T1 (de) | Mittel zur ortsspezifischen alkylierung. | |
| EP1176959A4 (en) | NEW PROLIN COMPOUNDS AS A MICROBICIDE AGENT | |
| ATE232531T1 (de) | Heterobizyklische derivate | |
| NO983970D0 (no) | Tricykliske forbindelser, deres fremstilling og anvendelse | |
| DE69524246D1 (de) | 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten | |
| ATE143019T1 (de) | Xanthin derivate | |
| DE60132484D1 (de) | Chinazolinderivate und -arzneimittel | |
| DE69414019D1 (de) | Bicyclische Stichstoff enthaltende Derivate als Prolyl-Endopeptidase Inhibitoren | |
| AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
| PT88003A (pt) | Processo para a preparacao de di-hidropiridinas condensadas com um anel carbociclico ou heterociclico | |
| EA200500521A1 (ru) | 3-фенилзамещенный пиридоиндолон, его получение и терапевтическое применение | |
| EP0882721A4 (en) | SIALIC ACIDS 2,7-DIDEOXY-7-FLUORO- 2, 3-DIDEHYDRO A QUADRUPLE SUBSTITUTION | |
| ATE269851T1 (de) | Benzimidazole derivate | |
| DE69329385D1 (de) | Thiazolin-derivate | |
| TR200003652T2 (tr) | Glisin antagonistleri olarak tetrahidrokuinolin türevleri. | |
| EA200400770A1 (ru) | Производные 5-(пиридин-3-ил)-1-азабицикло[3.2.1]октана, их получение и применение в терапии | |
| DK0485219T3 (da) | Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser | |
| ATE233739T1 (de) | Neue parabansäure-derivate als aldose-reduktase inhibitoren | |
| DK233788A (da) | Herbicid | |
| IT1205114B (it) | 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono | |
| NO20005820D0 (no) | Pyrazolo[1,5-a]pyrimidin-derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |